V019-9427 Screening compound: N-({2-[(2-chlorophenyl)methanesulfonyl]-1-(2-methoxyethyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]cyclopentanecarboxamide

V019-9427 Screening compound: N-({2-[(2-chlorophenyl)methanesulfonyl]-1-(2-methoxyethyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]cyclopentanecarboxamide
V019-9427 Screening compound: N-({2-[(2-chlorophenyl)methanesulfonyl]-1-(2-methoxyethyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]cyclopentanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-9427
N-({2-[(2-chlorophenyl)methanesulfonyl]-1-(2-methoxyethyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]cyclopentanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-9427

Molecular Formula

C26H37ClN4O5S (C26 H37 ClN4 O5 S)

Compound Name

N-({2-[(2-chlorophenyl)methanesulfonyl]-1-(2-methoxyethyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]cyclopentanecarboxamide

IUPAC name

N-({2-[(2-chlorophenyl)methanesulfonyl]-1-(2-methoxyethyl)-1H-imidazol-5-yl}methyl)-N-[2-(morpholin-4-yl)ethyl]cyclopentanecarboxamide

SMILES

COCCn1c(S(Cc(cccc2)c2Cl)(=O)=O)ncc1CN(CCN1CCOCC1)C(C1CCCC1)=O

InChI

InChI=1S/C26H37ClN4O5S/c1-35-15-14-31-23(18-28-26(31)37(33,34)20-22-8-4-5-9-24(22)27)19-30(25(32)21-6-2-3-7-21)11-10-29-12-16-36-17-13-29/h4-5,8-9,18,21H,2-3,6-7,10-17,19-20H2,1H3

InChI Key

UEOLLIBVWLKCLT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19824636

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

553.12

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.841

Distribution Coefficient, logD

2.800

Water Solubility, LogSw

-3.16

Polar Surface Area

77.611

Acid Dissociation Constant (pKa)

20.02

Base Dissociation Constant (pKb)

6.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

61.50

V019-9427 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Anti-HIV1 Library (19540 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V019-9427 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-9427?
Check Price and Availability of V019-9427, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-9427 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-9427
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-9427
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-9427 available by request